£185.99

Duloxetine: Clinical Uses, Mechanism of Action and Efficacy

Pharmacology

Price data last checked 116 day(s) ago - refreshing...

View at Amazon

We'll watch every seller, every day. One email when your price arrives.

This is the most expensive it has ever been. Walk away.

£186 today · previous high £186 · all-time low £177

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey

↓ Forecast
where the price is heading next

↓ Statistics
all-time high & low, recent range

↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 615 days • 615 data points (No recent data available)

Historical

Generating forecast...

Price Distribution

Price distribution over 615 days • 3 price levels

Days at Price

Current Price

Price Analysis

Most common price: £186 (445 days, 72.4%)

Price range: £177 - £186

Price levels: 3 different prices over 615 days

Description

The class of serotonin and noradrenaline reuptake inhibitors (or SNRIs) were introduced into clinical use as a result of the perceived short-comings of other antidepressant medications. Considerations of efficacy, side effects and tolerability have consistently indicated that there is a clinical need for agents demonstrating improvements in one or more of these domains. Since its introduction in 2007, duloxetine, a representative of the SNRI class, has been shown to be as effective for the treatment of major depression as agents with a longer history of use. In addition, duloxetine has demonstrated efficacy in a number of other conditions and has been extensively investigated in the treatment of generalised anxiety disorder and neuropathic pain states. The effectiveness of duloxetine in other anxiety states is not as soundly investigated, but the extant evidence is reviewed. Such disorders represent a fertile ground to explore the boundaries of duloxetine therapeutics, with the attended possibility of significant benefits to a broader patient cohort. This volume brings together the clinical evidence for efficacy in these important conditions. Additionally, it explores in detail the pharmacokinetics, metabolism and mechanism of action of the drug. All medications have side effects associated with their use and duloxetine is no exception. A detailed examination of the presentation and incidence of common events associated with the use of the drug as well as rarer treatment emergent adverse events is outlined. Duloxetine presents itself as a first line treatment of major depressive disorder and as a clinically significant treatment for depressive disorders co-morbid with anxiety and pain states.

Product Specifications

Format: hardcover
ASIN: 1536143278
Category: Books > Subjects > Health, Family & Lifestyle > Medical & Healthcare Practitioners > Other Branches of Medicine > Pharmacology
Domain: Amazon UK
Release Date: 23 November 2018
Listed Since: 07 August 2018

Barcode

No barcode data available

Duloxetine: Clinical Uses, Mechanism of Action and Efficacy

This is the most expensive it has ever been. Walk away.

Price History & Forecast

Price Distribution

Price Analysis

Description

Product Specifications

Barcode

Similar Products You Might Like

Antidepressants: Past, Present and Future: 157 (Handbook of Experimental Pharmacology, 157)

Antidepressants: Past, Present and Future: 157 (Handbook of Experimental Pharmacology, 157)

Differenzierte Therapie mit trizyklischen Antidepressiva

Antidepressants (Milestones in Drug Therapy)

Evidence-biased Antidepressant Prescription: Overmedicalisation, Flawed Research, and Conflicts of Interest

Let Them Eat Prozac: The Unhealthy Relationship Between the Pharmaceutical Industry and Depression (Disease and Desire)

Neuro-Psychopharmaka Ein Therapie-Handbuch: Band 3: Antidepressiva, Phasenprophylaktika und Stimmungsstabilisierer

Pharmacotherapy of Depression

Melatonin, Neuroprotective Agents and Antidepressant Therapy

The Myth of Depression as Disease: Limitations and Alternatives to Drug Treatment (Contemporary Psychology)

Neurobiology of Depression: Road to Novel Therapeutics

Prescriber's Guide: Antidepressants: Stahl's Essential Psychopharmacology

Antidepressants: Types, Efficiency & Possible Side Effects (Depression-Causes, Diagnosis, and Treatment)

Antidepressants: New Pharmacological Strategies (Contemporary Neuroscience)

Antidepressants: New Pharmacological Strategies (Contemporary Neuroscience)

Depression (Primer On Series)

Prevention and Early Treatment of Depression Through the Life Course (Depression and Personality)

Pharmacotherapy of Child and Adolescent Psychiatric Disorders

Major Depressive Disorder: Risk Factors, Characteristics & Treatment Options (Psychiatry - Theory, Applications and Treatments)

Focus on Serotonin Uptake Inhibitor Research (Nova Biomedical)

Depression as a Systemic Illness

Trends in Serotonin Reuptake Inhibitor Research

Major Depressive Disorder (Oxford American Psychiatry Library)

The Pharmacological Guide to Paroxetine (Pharmacology - Research, Safety Testing and Regulation)